Wenyi Wei

机构：Beth Israel Deaconess Medical Center, Harvard University, Harbin Medical University, Hadassah Medical Center, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0003-0512-3811

发表论文 444 篇 · 总被引 28283 次 · h-index 91

代表论文

• Targeted destruction of VISTA boosts anti-tumor immunotherapy (2025 · Cell Research · 被引 5)
• CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy (2026 · Journal for ImmunoTherapy of Cancer · 被引 4)
• Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy (2025 · Cell Research · 被引 4)
• USP2 stabilizes POU2F3 and represents a therapeutic vulnerability in POU2F3-positive small cell lung cancer (2026 · Cell Press Blue · 被引 1)
• Molecular insights for the tumor suppressor role of SPOP in prostate cancer (2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 1)
• Deubiquitinase-Targeting Chimeras Mediated Stabilization of Tumor Suppressive E3 Ligase Proteins as a Strategy for Cancer Therapy (2026 · UNC Libraries)